Demographic and Clinical Characteristics of Patients
| Characteristic | Patients (n = 61) |
|---|---|
| Age (y) | 59 (48–65) |
| Sex | |
| Female | 18 (30) |
| Male | 43 (70) |
| Disease stage at study entry | |
| I | 1 (2) |
| II | 19 (31) |
| III | 8 (13) |
| IV | 33 (54) |
| Diagnosis on central histologic review | |
| DLBCL | 53 (87) |
| PMBCL | 8 (13) |
| High-grade B-cell lymphoma | 0 |
| Double- or triple-hit rearrangement: MYC plus BCL2, BCL6, or both (n = 53) | 6 (11) |
| Cell of origin of cancer | |
| Germinal center B-cell type | 16 (26) |
| Nongerminal center B-cell type | 28 (46) |
| Activated B-cell | 2 (3) |
| Missing data | 15 (25) |
| Number of previous lines of antineoplastic therapy | |
| 1 | 1 (2) |
| 2 | 33 (54) |
| 3 | 16 (26) |
| 4–8 | 11 (18) |
| Relapse after last therapy | 6 (10) |
| Refractory DLBCL | 55 (90) |
| CAR-T product | |
| Axi-cel | 34 (56) |
| Tisa-cel | 27 (44) |
Data are number with percentage in parentheses. Continuous data are median with IQR in parentheses.